Robert Barrow sold $1.3M of Definium Therapeutics (DFTX)

Executed Jun 25, disclosed Jun 26, 1 day later.

Value, as filed

$1.3M

29,208 sh × $45.03

Executed

Jun 25

the trade date, as filed

Disclosed

Jun 26

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RB Robert Barrow Chief Executive Officer profile →

Robert Barrow (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in MNMD. The largest single filing was $1.3M of DFTX (29,208 sh × $45.03, as filed), executed Jun 25.

The name

DFTX Definium Therapeutics, Inc. DFTX · Healthcare · 9 filings in 24 months ticker →

Healthcare · Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Robert Barrow in DFTX

DFTXSALE Definium Therapeutics, Inc. $722K
19,023 sh × $37.94
Exec Sep 3
Filed Sep 4 · 9:30 PM ET DFTXSALE Definium Therapeutics, Inc. $451K
24,431 sh × $18.47
Exec Mar 25
Filed Mar 26 · 5:30 PM ET